cigna glp-1 coverage news today Weight loss drugs' high costs prompt to cut employee health plan Overview | Cigna Healthcare Newsroom

Emerging evidence suggests that GLP1 therapy can: Reduce hepatic fat content, as shown in MRI-PDFF studies Lower markers of liver inflammation and fibrosis Improve insulin sensitivity and metabolic control Although most trials focus on obese or diabetic populations, livercentric endpoints are increasingly evaluated, and benefits appear to extend beyond weight loss alone

"Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study"

Regulatory classification shouldnt be interpreted as evidence of clinical safety or effectiveness

Safety and Interactions Introduction Managing your health often feels like a balancing act, especially when you are navigating a new weight loss journey

Have enough supply to execute a controlled taper rather than an abrupt stop if your vendor goes offline